Fatal Outcome of Recombinant Factor VIIa in Heart Transplantation With Extracorporeal Membrane Oxygenation

Annals of Thoracic Surgery

Volumn 89, Issue 5, 2010, Pages 1643-1645

  Syburra, Thomas ^a,b   Lachat, Mario ^a   Genoni, Michele ^b   Wilhelm, Markus J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; AORTA CLAMPING; ARTICLE; AUTOPSY; CANDIDA ALBICANS; CANNULATION; CASE REPORT; EXPLANT; EXTRACORPOREAL OXYGENATION; FEMORAL VEIN; GENERAL CONDITION DETERIORATION; GRAFT RECIPIENT; HEART ASSIST DEVICE; HEART FAILURE; HEART GRAFT; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INTRACARDIAC THROMBOSIS; MALE; MITRAL VALVE REPLACEMENT; MYCOSIS; OFF LABEL DRUG USE; OPERATION DURATION; PRIORITY JOURNAL; PULMONARY VEIN; RESUSCITATION; BLEEDING; DISEASE COURSE; FATALITY; GRAFT REJECTION; HOSPITAL ADMISSION; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RISK ASSESSMENT;

AUTOPSY; BLOOD LOSS, SURGICAL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR VIIA; FATAL OUTCOME; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RISK ASSESSMENT; WAITING LISTS;

EID: 77953046857     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.09.039     Document Type: Article

References (9)

1. Roberts H.R., Monroe D.M., and Hoffman M. Safety profile of recombinant factor VIIa. Semin Hematol 41 (2004) 101-108
2. Warren O., Mandal K., Hadjianastassiou V., et al. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 83 (2007) 707-714
3. Lichtman A.D., Carullo V., Minhaj M., and Karkouti K. Massive intraoperative thrombosis and death after recombinant activated factor VII administration. J Cardiothorac Vasc Anesth 21 (2007) 897-902
4. Gandhi M.J., Pierce R.A., Zhang L., Moon M.R., Despotis G.J., and Moazami N. Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg 2 (2007) 32
5. Brose S., Sirbu H., Engel M., Kuhlen R., and Autschbach R. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation. Thorac Cardiovasc Surg 53 (2005) 389-390
6. Bui J.D., Despotis G.D., Trulock E.P., Patterson G.A., and Goodnough L.T. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surgery 124 (2002) 852-854
7. Chalwin R.P., Tiruvoipati R., and Peek G.J. Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 34 (2008) 685-686
8. Veldman A., Neuhaeuser C., Akintuerk H., et al. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth 17 (2007) 1176-1181
9. Wittenstein B., Ng C., Ravn H., and Goldman A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med 6 (2005) 473-476